Asia Pacific Carbapenem-Based Antibiotics Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Asia Pacific Carbapenem-Based Antibiotics Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Asia Pacific Carbapenem-Based Antibiotics Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Asia Pacific Carbapenem-Based Antibiotics Market Regional Analysis

6.2 Asia Pacific Carbapenem-Based Antibiotics Market Revenue 2019-2028 (US$ Million)

6.3 Asia Pacific Carbapenem-Based Antibiotics Market Forecast Analysis

7. Asia Pacific Carbapenem-Based Antibiotics Market Analysis – by Type

7.1 Meropenem

7.1.1 Overview
7.1.2 Meropenem: Asia Pacific Carbapenem-Based Antibiotics Market – Revenue and Forecast, 2019-2028 (US$ Million)

7.2 Doripenem

7.2.1 Overview
7.2.2 Doripenem: Asia Pacific Carbapenem-Based Antibiotics Market – Revenue and Forecast, 2019-2028 (US$ Million)

7.3 Imipenem

7.3.1 Overview
7.3.2 Imipenem: Asia Pacific Carbapenem-Based Antibiotics Market – Revenue and Forecast, 2019-2028 (US$ Million)

7.4 Tebipenem

7.4.1 Overview
7.4.2 Tebipenem: Asia Pacific Carbapenem-Based Antibiotics Market – Revenue and Forecast, 2019-2028 (US$ Million)

8. Asia Pacific Carbapenem-Based Antibiotics Market Analysis – by Indication

8.1 Bacterial Meningitis

8.1.1 Overview
8.1.2 Bacterial Meningitis: Asia Pacific Carbapenem-Based Antibiotics Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.2 Acute Pelvic Infections

8.2.1 Overview
8.2.2 Acute Pelvic Infections: Asia Pacific Carbapenem-Based Antibiotics Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.3 Respiratory Tract Infections

8.3.1 Overview
8.3.2 Respiratory Tract Infections: Asia Pacific Carbapenem-Based Antibiotics Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.4 Intra-Abdominal Infections

8.4.1 Overview
8.4.2 Intra-Abdominal Infections: Asia Pacific Carbapenem-Based Antibiotics Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.5 Urinary Tract Infections

8.5.1 Overview
8.5.2 Urinary Tract Infections: Asia Pacific Carbapenem-Based Antibiotics Market – Revenue and Forecast, 2019-2028 (US$ Million)

9. Asia Pacific Carbapenem-Based Antibiotics Market Analysis – by Distribution Channel

9.1 Retail Pharmacies

9.1.1 Overview
9.1.2 Retail Pharmacies: Asia Pacific Carbapenem-Based Antibiotics Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.2 Online Pharmacies

9.2.1 Overview
9.2.2 Online Pharmacies: Asia Pacific Carbapenem-Based Antibiotics Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.3 Hospital Pharmacies

9.3.1 Overview
9.3.2 Hospital Pharmacies : Asia Pacific Carbapenem-Based Antibiotics Market – Revenue and Forecast, 2019-2028 (US$ Million)

10. Asia Pacific Carbapenem-Based Antibiotics Market – Asia-Pacific Analysis

10.1 Overview

10.2 Asia-Pacific

10.2.1 Asia Pacific Carbapenem-Based Antibiotics Market Breakdown, by Key Country, 2022 and 2028 (%)
10.2.1.1 Asia Pacific Carbapenem-Based Antibiotics Market – Revenue and Forecast Analysis – by Country
10.2.1.1 China: Asia Pacific Carbapenem-Based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.1.1 China: Asia Pacific Carbapenem-Based Antibiotics Market Breakdown, by Type
10.2.1.1.2 China: Asia Pacific Carbapenem-Based Antibiotics Market Breakdown, by Indication
10.2.1.1.3 China: Asia Pacific Carbapenem-Based Antibiotics Market Breakdown, by Distribution Channel

10.2.1.2 India: Asia Pacific Carbapenem-Based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.2.1 India: Asia Pacific Carbapenem-Based Antibiotics Market Breakdown, by Type
10.2.1.2.2 India: Asia Pacific Carbapenem-Based Antibiotics Market Breakdown, by Indication
10.2.1.2.3 India: Asia Pacific Carbapenem-Based Antibiotics Market Breakdown, by Distribution Channel

10.2.1.3 Japan: Asia Pacific Carbapenem-Based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.3.1 Japan: Asia Pacific Carbapenem-Based Antibiotics Market Breakdown, by Type
10.2.1.3.2 Japan: Asia Pacific Carbapenem-Based Antibiotics Market Breakdown, by Indication
10.2.1.3.3 Japan: Asia Pacific Carbapenem-Based Antibiotics Market Breakdown, by Distribution Channel

10.2.1.4 Australia: Asia Pacific Carbapenem-Based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.4.1 Australia: Asia Pacific Carbapenem-Based Antibiotics Market Breakdown, by Type
10.2.1.4.2 Australia: Asia Pacific Carbapenem-Based Antibiotics Market Breakdown, by Indication
10.2.1.4.3 Australia: Asia Pacific Carbapenem-Based Antibiotics Market Breakdown, by Distribution Channel

10.2.1.5 Rest of Asia-Pacific : Asia Pacific Carbapenem-Based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.5.1 Rest of Asia-Pacific : Asia Pacific Carbapenem-Based Antibiotics Market Breakdown, by Type
10.2.1.5.2 Rest of Asia-Pacific : Asia Pacific Carbapenem-Based Antibiotics Market Breakdown, by Indication
10.2.1.5.3 Rest of Asia-Pacific : Asia Pacific Carbapenem-Based Antibiotics Market Breakdown, by Distribution Channel

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview

12.2 Market Initiative

12.3 Partnerships and Collaborations

12.4 Other Developments

13. Company Profiles

13.1 ACS Dobfar S.p.A

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Iterum Therapeutics plc

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 DAEWOONG PHARMACEUTICAL CO., LTD

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Aurobindo Pharma Ltd

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Gland Pharma Limited

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Merck & Co., Inc.

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Sumitomo Dainippon Pharma Co., Ltd.

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Savior Lifetec

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 Pfizer Inc.

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 Spero Therapeutics

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights

14.2 List of Abbreviations

Asia Pacific Carbapenem-Based Antibiotics Market